Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-11-067193
Filing Date
2011-03-15
Accepted
2011-03-15 16:11:00
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d10ka.htm 10-K/A 1278801
2 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 2273
3 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1920
4 CERTIFICATION OF THE PEO AND PFO PURSUANT TO SECTION 302 dex311.htm EX-31.1 6924
5 CERTIFICATION OF THE PEO AND PFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 3227
6 GRAPHIC g157596g68t45.jpg GRAPHIC 48689
7 GRAPHIC g157596g74j09.jpg GRAPHIC 46038
  Complete submission text file 0001193125-11-067193.txt   1425161
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

EIN.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-31141 | Film No.: 11688720
SIC: 2834 Pharmaceutical Preparations